Angiotensin III stimulates ERK1/2 mitogen-activated protein kinases and astrocyte growth in cultured rat astrocytes

Neuropeptides

Volumn 45, Issue 5, 2011, Pages 329-335

  Clark, Michelle A ^a   Tran, Hsieu ^a   Nguyen, Chinh ^a  

^a NOVA SOUTHEASTERN UNIVERSITY   (United States)

Author keywords

Angiotensin II; Angiotensin III; Astrocyte growth; Mitogen activated protein kinase

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANGIOTENSIN III; LOSARTAN; MITOGEN ACTIVATED PROTEIN KINASE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASTROCYTE; ASTROCYTOSIS; BRAIN STEM; CELL CULTURE; CELL GROWTH; CEREBELLUM; CONTROLLED STUDY; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; NONHUMAN; PRIORITY JOURNAL; RAT; STIMULATION;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN II TYPE 2 RECEPTOR BLOCKERS; ANGIOTENSIN III; ANIMALS; ASTROCYTES; BRAIN STEM; CELLS, CULTURED; CEREBELLUM; ENZYME INHIBITORS; FLAVONOIDS; IMIDAZOLES; LOSARTAN; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY;

RATTUS;

EID: 80052443852     PISSN: 01434179     EISSN: 15322785     Source Type: Journal    
DOI: 10.1016/j.npep.2011.07.002     Document Type: Article

References (45)

1. Abhold R.H., Sullivan M.J., Wright J.W., Harding J.W. Binding, degradation and pressor activity of angiotensins II and III after aminopeptidase inhibition with amastatin and bestatin. J. Pharmacol. Exp. Ther. 1987, 242:957-962.
2. Bader M., Peters J., Baltatu O., Muller D.N., Luft F.C., Ganten D. Tissue renin-angiotensin systems: new insights from experimental animal models in hypertension research. J. Mol. Med. 2001, 79:76-102.
3. Banegas I., Prieto I., Vives F., Alba F., Duran R., Segarra A.B., de Gasparo M., Ramirez M. Plasma aminopeptidase activities in rats after left and right intrastriatal administration of 6-hydroxydopamine. Neuroendocrinology 2004, 80:219-224.
4. Banegas I., Prieto I., Vives F., Alba F., de Gasparo M., Segarra A.B., Hermoso F., Duran R., Ramirez M. Brain aminopeptidases and hypertension. J. Renin. Angiotensin Aldosterone Syst. 2006, 7:129-134.
5. Blume A., Undeutsch C., Zhao Y., Kaschina E., Culman J., Unger T. ANG III induces expression of inducible transcription factors of AP-1 and Krox families in rat brain. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 289:R845-850.
6. Clark M. Angiotensin II activates mitogen-activated protein kinases and stimulates growth in rat medullary astrocytes. FASEB J. 2001, A1169.
7. Clark M.A., Gonzalez N. Angiotensin II stimulates rat astrocyte mitogen-activated protein kinase activity and growth through EGF and PDGF receptor transactivation. Regul. Pept. 2007, 144:115-122.
8. Clark M.A., Gonzalez N. Src and Pyk2 mediate angiotensin II effects in cultured rat astrocytes. Regul. Pept. 2007, 143:47-55.
9. Clark M.A., Guillaume G., Pierre-Louis H.C. Angiotensin II induces proliferation of cultured rat astrocytes through c-Jun N-terminal kinase. Brain Res. Bull. 2008, 75:101-106.
10. Delaney J., Chiarello R., Villar D., Kandalam U., Castejon A.M., Clark M.A. Regulation of c-fos, c-jun and c-myc gene expression by angiotensin II in primary cultured rat astrocytes: role of ERK1/2 MAP kinases. Neurochem. Res. 2008, 33:545-550.
11. Force T., Bonventre J.V. Growth factors and mitogen-activated protein kinases. Hypertension 1998, 31:152-161.
12. Freeman E.J., Chisolm G.M., Ferrario C.M., Tallant E.A. Angiotensin-(1-7) inhibits vascular smooth muscle cell growth. Hypertension 1996, 28:104-108.
13. Harding J.W., Yoshida M.S., Dilts R.P., Woods T.M., Wright J.W. Cerebroventricular and intravascular metabolism of [125I]angiotensins in rat. J. Neurochem. 1986, 46:1292-1297.
14. Harding J.W., Felix D., Sullivan M.J., Camara C.A., Erickson J.B., Regulja I., Abhold R.F., Wright J.W. The pivotal role at angiotensin III in the brain angiotensin system. Proc. West Pharmacol. Soc. 1987, 30:11-15.
15. Hus-Citharel A., Gasc J.M., Zini S., Marchetti J., Roques B., Corvol P., Llorens-Cortes C. Aminopeptidase A activity and angiotensin III effects on [Ca2+]i along the rat nephron. Kidney Int. 1999, 56:850-859.
16. Johnson A., Thunhorst R.L. Sensory mechanisms in the behavioral control of body fluid balance. thirst and salt appetite 1995, Academic Press, New York.
17. Kirby R.F., Thunhorst R.L., Johnson A.K. Effects of a non-peptide angiotensin receptor antagonist on drinking and blood pressure responses to centrally administered angiotensins in the rat. Brain Res. 1992, 576:348-350.
18. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951, 193:265-275.
19. Lu D., Yang H., Raizada M.K. Angiotensin II regulation of neuromodulation: downstream signaling mechanism from activation of mitogen-activated protein kinase. J. Cell Biol. 1996, 135:1609-1617.
20. McKinley M.J., Albiston A.L., Allen A.M., Mathai M.L., May C.N., McAllen R.M., Oldfield B.J., Mendelsohn F.A., Chai S.Y. The brain renin-angiotensin system: location and physiological roles. Int. J. Biochem. Cell Biol. 2003, 35:901-918.
21. Mii S., Khalil R.A., Morgan K.G., Ware J.A., Kent K.C. Mitogen-activated protein kinase and proliferation of human vascular smooth muscle cells. Am. J. Physiol. 1996, 270:H142-150.
22. Mukoyama M., Nakajima M., Horiuchi M., Sasamura H., Pratt R.E., Dzau V.J. Expression cloning of type 2 angiotensin II receptor reveals a unique class of seven-transmembrane receptors. J. Biol. Chem. 1993, 268:24539-24542.
23. Murphy T.J., Alexander R.W., Griendling K.K., Runge M.S., Bernstein K.E. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature 1991, 351:233-236.
24. Raizada M.K., Phillips M.I., Crews F.T., Sumners C. Distinct angiotensin II receptor in primary cultures of glial cells from rat brain. Proc. Natl. Acad. Sci. USA 1987, 84:4655-4659.
25. Raizada M.K., Rydzewski B., Lu D., Sumners C. Angiotensin II type 1 receptor-mediated stimulation of c-fos gene expression in astroglial cultures. Am. J. Physiol. 1993, 265:C1046-1049.
26. Reaux A., Fournie-Zaluski M.C., David C., Zini S., Roques B.P., Corvol P., Llorens-Cortes C. Aminopeptidase A inhibitors as potential central antihypertensive agents. Proc. Natl. Acad. Sci. USA 1999, 96:13415-13420.
27. Reaux-Le Goazigo A., Iturrioz X., Fassot C., Claperon C., Roques B.P., Llorens-Cortes C. Role of angiotensin III in hypertension. Curr. Hypertens. Rep. 2005, 7:128-134.
28. Reid I.A. Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am. J. Physiol. 1992, 262:E763-778.
29. Rodriguez-Campos M., Kadarian C., Rodano V., Bianciotti L., Fernandez B., Vatta M. AT-1 receptor and phospholipase C are involved in angiotensin III modulation of hypothalamic noradrenergic transmission. Cell Mol. Neurobiol. 2000, 20:747-762.
30. Skurk T., Lee Y.M., Rohrig K., Hauner H. Effect of angiotensin peptides on PAI-1 expression and production in human adipocytes. Horm. Metab. Res. 2001, 33:196-200.
31. Speth R.C., Karamyan V.T. The significance of brain aminopeptidases in the regulation of the actions of angiotensin peptides in the brain. Heart Fail. Rev. 2008, 13:299-309.
32. Stornetta R.L., Hawelu-Johnson C.L., Guyenet P.G., Lynch K.R. Astrocytes synthesize angiotensinogen in brain. Science 1988, 242:1444-1446.
33. Tallant E.A., Higson J.T. Angiotensin II activates distinct signal transduction pathways in astrocytes isolated from neonatal rat brain. Glia 1997, 19:333-342.
34. Tallant E.A., Jaiswal N., Diz D.I., Ferrario C.M. Human astrocytes contain two distinct angiotensin receptor subtypes. Hypertension 1991, 18:32-39.
35. Tallant E.A., Diz D.I., Ferrario C.M. Identification of AT1 receptors on cultured astrocytes. Adv. Exp. Med. Biol. 1996, 396:121-129.
36. Touyz R.M., Schiffrin E.L. Signal transduction in hypertension: part I. Curr. Opin. Nephrol. Hypertens. 1993, 2:5-16.
37. Touyz R.M., El Mabrouk M., He G., Wu X.H., Schiffrin E.L. Mitogen-activated protein/extracellular signal-regulated kinase inhibition attenuates angiotensin II-mediated signaling and contraction in spontaneously hypertensive rat vascular smooth muscle cells. Circ. Res. 1999, 84:505-515.
38. Veerasingham S.J., Raizada M.K. Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives. Br. J. Pharmacol. 2003, 139:191-202.
39. Wright J.W., Sullivan M.J., Harding J.W. Dysfunction of central angiotensinergic aminopeptidase activity in spontaneously hypertensive rats. Neurosci. Lett. 1985, 61:351-356.
40. Wright J.W., Bechtholt A.J., Chambers S.L., Harding J.W. Angiotensin III and IV activation of the brain AT1 receptor subtype in cardiovascular function. Peptides 1996, 17:1365-1371.
41. Xue B., Johnson A.K., Hay M. Sex differences in angiotensin II- induced hypertension. Braz. J. Med. Biol. Res. 2007, 40:727-734.
42. Yang C.C., Chan J.Y., Chan S.H. Central effect of angiotensin III on caudal hypoglossal neurons in rats. Am. J. Physiol. 1995, 268:R1242-1248.
43. Yang H., Lu D., Yu K., Raizada M.K. Regulation of neuromodulatory actions of angiotensin II in the brain neurons by the Ras-dependent mitogen-activated protein kinase pathway. J. Neurosci. 1996, 16:4047-4058.
44. Yang H., Lu D., Vinson G.P., Raizada M.K. Involvement of MAP kinase in angiotensin II-induced phosphorylation and intracellular targeting of neuronal AT1 receptors. J. Neurosci. 1997, 17:1660-1669.
45. Zini S., Fournie-Zaluski M.C., Chauvel E., Roques B.P., Corvol P., Llorens-Cortes C. Identification of metabolic pathways of brain angiotensin II and III using specific aminopeptidase inhibitors: predominant role of angiotensin III in the control of vasopressin release. Proc. Natl. Acad. Sci. USA 1996, 93:11968-11973.